Hot Stocks: Brokerage view on ICICI Bank, L&T and Biocon
“The stock is a re-rating candidate for a late-cycle beneficiary, but L&T’s business currently lacks momentum. However, relative evaluation peer stocks have re-rated dramatically,” Credit Suisse said.
